Sentinel Study Transparency: FDA Tells Sponsors To Watch Journals, Conferences, Its Website For Results
Executive Summary
MaPP indicates limited circumstances when Office of Surveillance and Epidemiology will tell a sponsor about the release of Sentinel safety study results.
You may also be interested in...
US FDA's Sentinel To Begin Expansion This Fall
Contracts for up to $220m to develop three new Sentinel centers will be awarded in September.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.